Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis - PubMed (original) (raw)
. 1993 Mar 15;150(6):2525-33.
Affiliations
- PMID: 8450228
Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis
K Hulkower et al. J Immunol. 1993.
Abstract
We have examined the expression of factors associated with the growth, differentiation, and chemotaxis of cells of the monocyte/macrophage series in the central nervous system of Lewis rats sensitized to develop experimental allergic encephalomyelitis. CSF-1 mRNA increased significantly over that found in control animals (sensitized with OVA in CFA or CFA alone). The elevation in the levels of this growth factor commenced immediately before the onset of early clinical signs and peaked immediately before maximal clinical incidence of disease. Expression of CSF-1 message declined to base-line values with resolution of the disease process. CSF-1 protein was also detected in the central nervous system at the height of clinical disease. Expression of the receptor for CSF-1, the proto-oncogene c-fms, also paralleled the early disease process. Elevated levels of c-fms mRNA were detected immediately before the onset and peaked at the height of clinical signs of disease. In contrast to CSF-1 levels, elevated c-fms message expression persisted after resolution of the acute phase of experimental allergic encephalomyelitis. Levels of macrophage chemotactic factor-1 message were also elevated immediately before the onset of clinical signs, peaked with the height of clinical disease, and declined with resolution of the disease. Unlike CSF-1 or c-fms, no endogenous macrophage chemotactic factor-1 message was detected in control animals. Macrophage chemotactic factor-1 protein was demonstrated by Western blot in the central nervous system at the height of clinical disease. The results support the conclusion that expression of factors that specifically target cells of the monocyte/macrophage series are an important component of the disease process in experimental allergic encephalomyelitis.
Similar articles
- Expression of the macrophage growth factor, CSF-1 and its receptor c-fms by a Hodgkin's disease-derived cell line and its variants.
Paietta E, Racevskis J, Stanley ER, Andreeff M, Papenhausen P, Wiernik PH. Paietta E, et al. Cancer Res. 1990 Apr 1;50(7):2049-55. Cancer Res. 1990. PMID: 2156611 - Regulation of CSF-1 receptor expression.
Hume DA, Yue X, Ross IL, Favot P, Lichanska A, Ostrowski MC. Hume DA, et al. Mol Reprod Dev. 1997 Jan;46(1):46-52; discussion 52-3. doi: 10.1002/(SICI)1098-2795(199701)46:1<46::AID-MRD8>3.0.CO;2-R. Mol Reprod Dev. 1997. PMID: 8981363 Review. - The role of macrophages in the regulation of primary tumor growth.
Walter S, Govoni D, Bottazzi B, Mantovani A. Walter S, et al. Pathobiology. 1991;59(4):239-42. doi: 10.1159/000163654. Pathobiology. 1991. PMID: 1883519 Review.
Cited by
- Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis.
Kennedy KJ, Karpus WJ. Kennedy KJ, et al. J Clin Immunol. 1999 Sep;19(5):273-9. doi: 10.1023/a:1020535423465. J Clin Immunol. 1999. PMID: 10535603 Review. - Chemokines and central nervous system disorders.
Karpus WJ. Karpus WJ. J Neurovirol. 2001 Dec;7(6):493-500. doi: 10.1080/135502801753248079. J Neurovirol. 2001. PMID: 11704881 Review. - 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes.
Xu J, Drew PD. Xu J, et al. J Neuroimmunol. 2006 Feb;171(1-2):135-44. doi: 10.1016/j.jneuroim.2005.10.004. Epub 2005 Nov 21. J Neuroimmunol. 2006. PMID: 16303184 Free PMC article. - Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer.
Yao Y, Tsirka SE. Yao Y, et al. Int J Biochem Cell Biol. 2014 Oct;55:51-9. doi: 10.1016/j.biocel.2014.08.002. Epub 2014 Aug 12. Int J Biochem Cell Biol. 2014. PMID: 25130440 Free PMC article. - Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Bielecki B, Jatczak-Pawlik I, Wolinski P, Bednarek A, Glabinski A. Bielecki B, et al. Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):367-76. doi: 10.1007/s00005-015-0339-9. Epub 2015 May 10. Arch Immunol Ther Exp (Warsz). 2015. PMID: 25957582 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous